Pharmadrug Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was CAD 0.419975 million compared to CAD 5.38 million a year ago. Basic loss per share from continuing operations was CAD 0.014 compared to CAD 0.049 a year ago.
For the six months, net loss was CAD 0.598748 million compared to CAD 7.44 million a year ago. Basic loss per share from continuing operations was CAD 0.014 compared to CAD 0.049 a year ago.